Whipps Cross University Hospital is a large university hospital in the locality of Whipps Cross in Leytonstone and is within Epping Forest in the London Borough of Waltham Forest, London, England. It is managed by Barts Health NHS Trust.

There are 734 (approx) beds in Whipps Cross University Hospital.

During the past decade, Whipps Cross University Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 37 clinical trials were completed, i.e. on average, 78.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 27 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whipps Cross University Hospital" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Pfizer" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Takeda" with 4 trials sponsored and "LEO Pharma" with 4 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whipps Cross University Hospital" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Barts & The London NHS Trust" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Whipps Cross University Hospital" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (7 trials), "Rheumatoid Arthritis" (5 trials), "Atopic Dermatitis" (4 trials) and "Colitis, Ulcerative" (4 trials). Many other conditions were trialed in "Whipps Cross University Hospital" in a lesser frequency.

Most popular intervention types in "Whipps Cross University Hospital" are "Drug" (59 trials), "Other" (8 trials), "Biological" (6 trials), "Procedure" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Baricitinib" (5 trials), "Etrasimod" (3 trials), "Guselkumab" (3 trials) and "Mirikizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Whipps Cross University Hospital" are 61 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Whipps Cross University Hospital". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Whipps Cross University Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Whipps Cross University Hospital, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".